| Judith Rivera, | |
|
305 Ave San Jose E, Aibonito, PR 00705-3733 | |
| (787) 991-7355 | |
| (787) 991-7361 |
| Full Name | Judith Rivera |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 305 Ave San Jose E, Aibonito, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851632798 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4369 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Judith Rivera, 305 Ave San Jose E, Aibonito, PR 00705-3733 Ph: (787) 991-7355 | Judith Rivera, 305 Ave San Jose E, Aibonito, PR 00705-3733 Ph: (787) 991-7355 |
News Archive
Helix BioPharma Corp. announced that it has received the necessary regulatory approvals in Germany to initiate its planned Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions.
Peanut allergies could become a thing of the past as breakthrough research from the University of South Australia develops a radically novel vaccination that's poised to cure the potentially life threatening condition.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for reduction in hyperactivity in mice treated with amphetamines. The mouse model screening was performed by the contract research organization, Cerca Insights.
Drug discovery company SCYNEXIS, Inc. today presented data supporting an impressive resistance profile for SCY-635—a novel, oral cyclophilin inhibitor being studied for the treatment of hepatitis C virus (HCV) infection. In the study, SCYNEXIS demonstrated that the hepatitis C virus required multiple mutations across two separate proteins in order to establish resistance to SCY-635. The majority of HCV drugs on the market and in development require only one targeted viral mutation to establish resistance.
Health law coverage includes how the measure's implementation impacts a variety of different populations, as well as other key policy issues.
› Verified 4 days ago
Mrs. Elsie Lidia Pagan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 Calle Baldorioty N, Aibonito, PR 00705 Phone: 787-735-4887 Fax: 787-735-4887 | |
Mrs. Maribel Rodriguez, PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: San Jose St. #300 Mercedita Serralles, Aibonito, PR 00705 Phone: 787-735-3025 Fax: 787-735-2725 | |
Mrs. Teresita De Jesus Alvarado-berrios, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 305 Ave San Jose E, Aibonito, PR 00705 Phone: 787-991-7355 Fax: 787-991-7361 | |
Prof. Alicia Ortiz, LCDA. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 154 Calle San Jose E, Aibonito, PR 00705 Phone: 787-735-6391 Fax: 787-735-6391 | |
Rafael Rivera, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: San Jose St #300, Aibonito, PR 00705 Phone: 787-735-3025 Fax: 787-735-3021 | |
Mrs. Carmen Enid Sierra, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Calle Jose Vazquez And Dr. Troyer, Bo Caonillas, Aibonito, PR 00705 Phone: 787-735-0384 Fax: 787-735-0384 | |
Dr. Anibal J. Caraballo Sr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr Pr 14 Km 80.4, Parque Industrial Bo. Pueblo, Aibonito, PR 00705 Phone: 787-739-8182 |